The Medical Letter on Drugs and Therapeutics
August 13, 2018 (Issue: 1553)
- U Panich et al. Ultraviolet radiation-induced skin aging: the role of DNA damage and oxidative stress in epidermal stem cell damage mediated skin aging. Stem Cells Int 2016; 2016:7370642.
- M Arnold et al. Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer 2018 April 16 (epub).
- Questions and answers: FDA announces new requirements for over-the-counter (OTC) sunscreen products marketed in the U.S. June 23, 2011. Available at: www.fda.gov. Accessed August 2, 2018.
- US Preventive Services Task Force. Behavorial counseling to prevent skin cancer: US Preventive Services Task Force recommendation statement. JAMA 2018; 319:1134.
- AAD statement on the safety of sunscreen. American Academy of Dermatology. October 22, 2015. Available at: www.aad.org. Accessed August 2, 2018.
- A new sunscreen agent. Med Lett Drugs Ther 2007; 49:41.
- JB Mancuso et al. Sunscreens: an update. Am J Clin Dermatol 2017; 18:643.
- H Ou-Yang et al. High-SPF sunscreens (SPF ≥70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts. J Am Acad Dermatol 2012; 67:1220.
- JC van der Pols et al. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15:2546.
- C Ulrich et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 month, prospective, case-control study. Br J Dermatol 2009; 161 (suppl 3:78).
- MC Hughes et al. Sunscreen and prevention of skin aging: a randomized trial. Ann Intern Med 2013; 158:781.
- CG Watts et al. Sunscreen use and melanoma risk among young Australian adults. JAMA Dermatol 2018 July 18 (epub).
- AC Green et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29:257.
- AR Heurung et al. Adverse reactions to sunscreen agents: epidemiology, responsible irritants and allergans, clinical characteristics, and management. Dermatitis 2014; 25:289.
- NR Janjua et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004; 123:57.
- GM Buck Louis et al. Urinary concentrations of benzophenone-type ultraviolet radiation filters and couples’ fecundity. Am J Epidemiol 2014; 180:1168.
- H Krause et al. Presence of benzophenones commonly used as UV filters and absorbers in paired maternal and fetal samples. Environ Int 2018; 110:51.
- SQ Wang et al. Safety of oxybenzone: putting numbers into perspective. Arch Dermatol 2011; 147:865.
- JA Ruszkiewicz et al. Neurotoxic effect of active ingredients in sunscreen products, a contemporary review. Toxicol Rep 2017; 4:245.
- Australian Government Department of Health. Therapeutic Goods Administration. Literature review on the safety of titanium dioxide and zinc oxide nanoparticles in sunscreens. January 11, 2017. Available at: www.tga.gov.au. Accessed August 2, 2018.
- CA Downs et al. Toxicopathological effects of the sunscreen UV filter, oxybenzone (benzophenone-3) on coral planulae and cultured primary cells and its environmental contamination in Hawaii and the U.S. Virgin Islands. Arch Environ Contam Toxicol 2016; 70:265.
- SL Schneider and HW Lim. Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad Dermatol 2018 June 28 (epub).
- AS Paller et al. New insights about infant and toddler skin: implications for sun protection. Pediatrics 2011; 128:92.
- P Isedeh et al. Teaspoon rule revisited: proper amount of sunscreen application. Photodermatol Photoimmunol Photomed 2013; 29:55.
- Insect repellents. Med Lett Drugs Ther 2016; 58:83.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.